T 1341/19 (High amylose durum wheat grains/BARILLA) of 3.9.2020

European Case Law Identifier: ECLI:EP:BA:2020:T134119.20200903
Date of decision: 03 September 2020
Case number: T 1341/19
Application number: 12195780.7
IPC class: A01H5/10
A21D2/18
C08B30/04
A23L1/16
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 280 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: High amylose durum wheat grains, meal and starch
Applicant name: Barilla G. e R. Fratelli S.p.A.
Opponent name: -
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention Art 53(b) (2007)
European Patent Convention Art 111(1) (2007)
European Patent Convention R 28(2) (2017)
Keywords: Sole claim request - exceptions to patentability (no); remittal to the examining division (yes)
Catchwords:

-

Cited decisions:
G 0003/19
Citing decisions:
-

Summary of Facts and Submissions

I. The appeal filed by the applicant (appellant) lies from the examining division's decision refusing European patent application No. 12 195 780.7, which was filed as a divisional application of European patent application No. 08 425 721.1 which was filed on 11 November 2008. The title of the application is "High amylose durum wheat grains, meal and starch".

II. In the decision under appeal the examining division held that the subject-matter of claims 1 to 3 and 9 of the set of claims filed with letter dated 19 April 2016 "falls under the exclusions from patentability as defined by Article 53(b) EPC and Rule 28(2) EPC" (see point 14).

III. With the statement of grounds of appeal, the appellant maintained the set of claims at issue in the decision under appeal as their sole claim request.

Claim 1 of that request reads as follows:

"1. Grain of tetraploid Sgp-1 double mutant homozygote durum wheat suitable for the production of food products, selected for the characteristic of not expressing the Sgp-Al and Sgp-Bl forms of the Sgp-1 gene, containing a durum wheat starch having an apparent amylose content of 40% or more by weight on the weight of the starch."

IV. In their statement of grounds of appeal the appellant requested that "the refusal decision by the Examining Division be set aside in its entirety and that European patent application No. 12195780 be granted on the basis of the set of claims filed on 19.04.2016" (see statement of grounds of appeal, point 2).

V. The board issued a communication pursuant to Article 15(1) RPBA setting out its preliminary opinion with respect to the appeal and invited the appellant to reconsider their requests.

VI. In response, the appellant submitted that the request contained in the statement of grounds of appeal was reformulated as follows: "it is requested that the refusal decision by the Examining Division be set aside and that European patent application No. 12195780 be remitted to the Examining Division for further prosecution pursuant to Art 111(1) EPC" (see letter dated 6 August 2020).

Reasons for the Decision

1. The appeal complies with Articles 106 to 108 and Rule 99 EPC and is therefore admissible.

Main (sole) request

Exceptions to patentability (Article 53(b) EPC)

2. The sole reason given by the examining division for refusing the application was that the subject-matter of claims 1 to 3 and 9 was excluded from patentability pursuant to Article 53(b) EPC and Rule 28(2) EPC.

3. In opinion G 3/19 of 14 May 2020 the Enlarged Board of Appeal held (see Conclusion) that:

"Taking into account developments after decisions G 2/12 and G 2/13 of the Enlarged Board of Appeal,

the exception to patentability of essentially biological processes for the production of plants or animals in Article 53(b) EPC has a negative effect on the allowability of product claims and product-by-process claims directed to plants, plant material or animals, if the claimed product is exclusively obtained by means of an essentially biological process or if the claimed process features define an essentially biological process."

4. However the Enlarged Board of Appeal also held (ibid.) that:

"This negative effect does not apply to European patents granted before 1 July 2017 and European patent applications which were filed before that date and are still pending."

5. Accordingly, as the present application was filed before 1 July 2017 and is still pending (see section I), the subject-matter of the claims of the sole claim request is not excluded from patentability pursuant to Article 53(b) EPC in conjunction with Rule 28(2) EPC.

6. The appeal is thus allowable.

Remittal (Article 111(1) EPC)

7. Pursuant to Article 111(1) EPC the board may either exercise any power within the competence of the department which was responsible for the decision appealed or remit the case to that department for further prosecution.

8. It is the primary function of appeal proceedings to give a judicial decision upon the correctness of the decision under appeal (see Case Law of the Boards of Appeal, 9th edition 2019, section V.A.1.1, second paragraph and decisions referred to there).

9. As explained in point 2 above, the sole reason for refusing the application was that the subject-matter of claims 1 to 3 and 9 of the main request was excluded from patentability pursuant to Article 53(b) EPC and Rule 28(2) EPC and the board reviews this decision (see points 3 to 6 above).

10. Accordingly, in line with the appellant's request, the board decides to remit the case to the examining division for further prosecution.

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the examining division for further prosecution.

Quick Navigation